Literature DB >> 10722739

GABA(A) receptor assembly. Identification and structure of gamma(2) sequences forming the intersubunit contacts with alpha(1) and beta(3) subunits.

T Klausberger1, K Fuchs, B Mayer, N Ehya, W Sieghart.   

Abstract

GABA(A) receptors are ligand-gated chloride channels composed of five homologous subunits that specifically recognize one another and assemble around an aqueous pore. To identify domains responsible for the specificity of subunit association, we constructed C-terminal truncated gamma(2) subunits, as well as mutated and chimeric fragments. From their ability to interfere with alpha(1)beta(3)gamma(2) receptor assembly and to associate with full-length subunits, we concluded that amino acid sequences gamma(2)-(91-104) and gamma(2)-(83-90) form the sites mediating assembly with alpha(1) and beta(3) subunits, respectively. Neural network-based secondary structure prediction, Monte Carlo optimization, and hydrophobicity analysis led to the conclusion that these sites also form the intersubunit contacts in the completely assembled receptor and provided important information on the benzodiazepine-binding site and structure of GABA(A) receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722739     DOI: 10.1074/jbc.275.12.8921

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Structural determinants of fast desensitization and desensitization-deactivation coupling in GABAa receptors.

Authors:  M T Bianchi; K F Haas; R L Macdonald
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

Review 2.  Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission.

Authors:  Josef T Kittler; Kristina McAinsh; Stephen J Moss
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6β22 and 6β2 GABA(A) receptor channel gating and expression.

Authors:  Ciria C Hernandez; Katharine N Gurba; Ningning Hu; Robert L Macdonald
Journal:  J Physiol       Date:  2011-09-19       Impact factor: 5.182

4.  GABRB3 mutation, G32R, associated with childhood absence epilepsy alters α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor expression and channel gating.

Authors:  Katharine N Gurba; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

5.  Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors.

Authors:  John R Bracamontes; Joe Henry Steinbach
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

Review 6.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

Review 7.  GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

Authors:  Bernhard Luscher; Thomas Fuchs; Casey L Kilpatrick
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

8.  Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors.

Authors:  Amulya Nidhi Shrivastava; Antoine Triller; Werner Sieghart; Isabella Sarto-Jackson
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

9.  Co-expression of γ2 subunits hinders processing of N-linked glycans attached to the N104 glycosylation sites of GABAA receptor β2 subunits.

Authors:  Wen-Yi Lo; Andre H Lagrange; Ciria C Hernandez; Katharine N Gurba; Robert L Macdonald
Journal:  Neurochem Res       Date:  2013-11-12       Impact factor: 3.996

10.  Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.

Authors:  Vaishali S Janve; Ciria C Hernandez; Kelienne M Verdier; Ningning Hu; Robert L Macdonald
Journal:  Ann Neurol       Date:  2016-05       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.